NCT00231491View on ClinicalTrials.gov

Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Overactive Bladder
Interventions
DRUG

Botulinum Toxin A (Botox )

Trial Locations (1)

92380

RAYMOND POINCARE Hospital, Garches

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00231491 - Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder. | Biotech Hunter | Biotech Hunter